Stability demonstrated in a pharmaceutical container is not universal stability in every specimen.
Study findings
The study used HPLC to examine commercial oral and parenteral clonazepam solutions repackaged in polypropylene syringes. Under the tested light and temperature conditions, drug loss remained below ten percent over thirty days, without observed crystallization or major pH or visual changes.
What limits the conclusion
The concentrations, excipients, container and handling were specified. Physicochemical stability does not independently establish sterility or validate storage of blood, urine or a different compounded preparation. Absence of visible change cannot replace chemical measurement.
Implications for case review
For a storage dispute, compare the actual formulation, container, temperature, light exposure and elapsed time with the study. The results cannot retrospectively authenticate an unknown syringe or determine biological-specimen loss. A general claim that clonazepam is stable omits the conditions that make the finding meaningful.
Source and related reading
Source: PMC12567341, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Catatonia in Anti-NMDA Receptor Encephalitis Persisted Despite a Clonazepam-Containing Regimen.
Leave a Reply